Podcast
Questions and Answers
What is a primary distinction between acute and chronic Immune Thrombocytopenic Purpura (ITP)?
What is a primary distinction between acute and chronic Immune Thrombocytopenic Purpura (ITP)?
- Acute ITP is self-limited, whereas chronic ITP involves persistent thrombocytopenia. (correct)
- Acute ITP presents with numerous skin lesions, while chronic ITP does not.
- Chronic ITP has a higher prevalence in children than acute ITP.
- Chronic ITP typically resolves spontaneously within six months.
What mechanism leads to increased platelet destruction in Immune Thrombocytopenic Purpura (ITP)?
What mechanism leads to increased platelet destruction in Immune Thrombocytopenic Purpura (ITP)?
- Platelets are overproduced in the bone marrow.
- Viral infections cause a direct lysis of platelets.
- Genetic mutations inhibit the production of platelets.
- Autoantibodies bind to platelets, triggering their destruction. (correct)
Which symptom is commonly associated with acute ITP in children?
Which symptom is commonly associated with acute ITP in children?
- Fatigue and weight loss
- Severe abdominal pain
- Persistent joint pain
- Petechiae and gum bleeding (correct)
In the case of chronic ITP, what demographic is predominantly affected?
In the case of chronic ITP, what demographic is predominantly affected?
Which of the following states a potential cause of secondary ITP?
Which of the following states a potential cause of secondary ITP?
What is the typical platelet count associated with acute ITP?
What is the typical platelet count associated with acute ITP?
Which clinical feature is least likely to be associated with chronic ITP?
Which clinical feature is least likely to be associated with chronic ITP?
What type of antibody is primarily associated with the destruction of platelets in acute ITP?
What type of antibody is primarily associated with the destruction of platelets in acute ITP?
What is a distinguishing feature of acute ITP compared to chronic ITP?
What is a distinguishing feature of acute ITP compared to chronic ITP?
Which cytokine is commonly increased in ITP pathogenesis?
Which cytokine is commonly increased in ITP pathogenesis?
What is the typical platelet count range observed in ITP?
What is the typical platelet count range observed in ITP?
Which of the following is a common diagnostic finding in the peripheral smear of an ITP patient?
Which of the following is a common diagnostic finding in the peripheral smear of an ITP patient?
What mechanism underlies the formation of antiplatelet antibodies in ITP?
What mechanism underlies the formation of antiplatelet antibodies in ITP?
Which of the following is NOT typically associated with primary ITP?
Which of the following is NOT typically associated with primary ITP?
What is the key difference in the management of acute ITP compared to chronic ITP?
What is the key difference in the management of acute ITP compared to chronic ITP?
Which mechanism is primarily involved in the pathogenesis of Immune Thrombocytopenic Purpura (ITP)?
Which mechanism is primarily involved in the pathogenesis of Immune Thrombocytopenic Purpura (ITP)?
Which of these tests is likely to show a prolonged result in ITP?
Which of these tests is likely to show a prolonged result in ITP?
What is typically observed in a peripheral blood film of a patient with ITP?
What is typically observed in a peripheral blood film of a patient with ITP?
What role do T cell tolerance failures play in ITP?
What role do T cell tolerance failures play in ITP?
What type of patient management is primarily indicated for a life-threatening hemorrhage in ITP?
What type of patient management is primarily indicated for a life-threatening hemorrhage in ITP?
Which of the following is NOT a characteristic feature of chronic ITP?
Which of the following is NOT a characteristic feature of chronic ITP?
What is one of the diagnostic evaluation techniques used for ITP?
What is one of the diagnostic evaluation techniques used for ITP?
Which of the following conditions could potentially lead to secondary ITP?
Which of the following conditions could potentially lead to secondary ITP?
What role does corticosteroids play in the treatment of ITP?
What role does corticosteroids play in the treatment of ITP?
Study Notes
Immune Thrombocytopenic Purpura (ITP)
- Autoimmune disorder leading to low platelet count and mucocutaneous bleeding.
- Characterized by the formation of antiplatelet antibodies targeting glycoproteins IIb-IIIa or Ib-IX on platelets, predominantly IgG type.
- About 80% of patients present with detectable antibody/platelet complexes.
- Common symptoms include easy bruisability and excess bleeding.
Types of ITP
-
Acute ITP:
- Typically affects children aged 2-6 years; self-limited, resolving within 2-6 months.
- Onset occurs 1-3 weeks post viral infections or vaccinations.
- Characterized by sudden platelet destruction and counts below 10,000/mm³.
- Symptoms: petechiae, gum bleeding, epistaxis, and possible intracranial hemorrhage.
-
Chronic ITP:
- Affects predominantly women aged 20-40 years with a ratio of 3:1 (F:M).
- Associated with persistent thrombocytopenia lasting over 6-12 months, without preceding infection.
- Characterized by relapses and remissions.
Pathogenesis
- Events include recognition of self-antigens and tolerance failures in T and B cells.
- Mechanisms involve altered cell communication pathways (B7/CD28, CD40/CD40L, Fas/FasL) and type-1/type-2 cytokine responses.
- Notable cytokine changes: increased IL-2, IL-10, M-CSF, and low TGF-β.
- Autoimmune mechanisms lead to increased platelet destruction by immune complexes.
Diagnostic Evaluation
-
Complete Blood Counts:
- Platelet count significantly reduced (10-100 x 10⁹/L).
- Hemoglobin levels vary, potentially leading to hypochromic microcytic anemia due to chronic blood loss.
-
Peripheral Smear:
- Thrombocytopenia visible with enlarged or giant platelets.
- White blood cells typically remain within normal limits.
-
Coagulation Studies:
- Bleeding time prolonged; PT and PTT remain normal.
-
Tests for Autoantibodies:
- Presence of platelet autoantibodies may be detected.
Clinical Features
- Symptoms are not specific but largely due to thrombocytopenia.
- Splenomegaly and lymphadenopathy are rare in primary ITP.
- Associated with increased risk of severe bleeding.
Peripheral Blood Smear and Bone Marrow Findings
- Peripheral blood smear shows near absence of platelets; presence of large young platelets.
- Bone marrow examination reveals hypercellularity with normal or increased megakaryocytes.
Management Approach
-
Acute ITP:
- Generally supportive; spontaneous remission expected.
-
Chronic ITP:
- Aim for maintaining platelet count above thresholds for spontaneous bruising.
-
Emergency Treatment:
- Discontinue medications reducing platelet function and manage blood pressure.
- Corticosteroids as first-line treatment; effective in 80% of cases.
- Intravenous immunoglobulin for patients with contraindications to steroids or life-threatening hemorrhage.
- Platelet transfusion reserved for significant bleeding or urgent surgical needs.
- Antifibrinolytic medications, like tranexamic acid, used to address mucosal bleeding.
- Consider splenectomy in emergencies, with prior vaccinations if feasible.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz explores Immune Thrombocytopenic Purpura (ITP), an autoimmune disorder marked by low platelet counts and increased mucocutaneous bleeding. It highlights the mechanisms of platelet destruction and symptoms associated with this condition. Test your knowledge about ITP and its implications.
